|
Vaccine Detail
Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen |
Vaccine Information |
- Vaccine Name: Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0004445
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- Steap1
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pcDNA3 expressed six-transmembrane epithelial antigen of the prostate (Garcia-Hernandez et al., 2007).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000132
- Immunization Route: subcutaneous injection
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Survival was significantly prolonged in mice vaccinated with mSTEAP using DNA, VRP (Venezuelan equine encephalitis virus-like replicon particles), or a combined strategy after tumor challenge compared with control mice. Although all STEAP-based vaccination strategies significantly slowed tumor growth in tumor-challenged mice, DNA vaccination followed by boosting with VRP was the most effective way of inducing protective immunity (Garcia-Hernandez et al., 2007).
|
References |
Garcia-Hernandez et al., 2007: Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer research. 2007; 67(3); 1344-1351. [PubMed: 17283172].
|
|